Silverfin false false 31/01/2026 01/02/2025 31/01/2026 Michael Considine 04/01/2024 27 May 2026 The principal activity of the company during the year was that of the provision of products and services for harm reduction services. 15386214 2026-01-31 15386214 bus:Director1 2026-01-31 15386214 core:CurrentFinancialInstruments 2026-01-31 15386214 core:CurrentFinancialInstruments 2025-01-31 15386214 2025-01-31 15386214 core:ShareCapital 2026-01-31 15386214 core:ShareCapital 2025-01-31 15386214 core:RetainedEarningsAccumulatedLosses 2026-01-31 15386214 core:RetainedEarningsAccumulatedLosses 2025-01-31 15386214 core:RemainingRelatedParties core:CurrentFinancialInstruments 2026-01-31 15386214 core:RemainingRelatedParties core:CurrentFinancialInstruments 2025-01-31 15386214 bus:OrdinaryShareClass1 2026-01-31 15386214 2025-02-01 2026-01-31 15386214 bus:FilletedAccounts 2025-02-01 2026-01-31 15386214 bus:SmallEntities 2025-02-01 2026-01-31 15386214 bus:AuditExemptWithAccountantsReport 2025-02-01 2026-01-31 15386214 bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 15386214 bus:Director1 2025-02-01 2026-01-31 15386214 2024-02-01 2025-01-31 15386214 bus:OrdinaryShareClass1 2025-02-01 2026-01-31 15386214 bus:OrdinaryShareClass1 2024-02-01 2025-01-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 15386214 (England and Wales)

ONE-USE HARM REDUCTION PRODUCTS LTD.

Unaudited Financial Statements
For the financial year ended 31 January 2026
Pages for filing with the registrar

ONE-USE HARM REDUCTION PRODUCTS LTD.

Unaudited Financial Statements

For the financial year ended 31 January 2026

Contents

ONE-USE HARM REDUCTION PRODUCTS LTD.

STATEMENT OF FINANCIAL POSITION

As at 31 January 2026
ONE-USE HARM REDUCTION PRODUCTS LTD.

STATEMENT OF FINANCIAL POSITION (continued)

As at 31 January 2026
Note 2026 2025
£ £
Current assets
Debtors 3 80,832 65,382
Cash at bank and in hand ( 35) 9,197
80,797 74,579
Creditors: amounts falling due within one year 4 ( 71,958) ( 60,296)
Net current assets 8,839 14,283
Total assets less current liabilities 8,839 14,283
Net assets 8,839 14,283
Capital and reserves
Called-up share capital 5 1,000 1,000
Profit and loss account 7,839 13,283
Total shareholder's funds 8,839 14,283

For the financial year ending 31 January 2026 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of One-use Harm Reduction Products Ltd. (registered number: 15386214) were approved and authorised for issue by the Director on 27 May 2026. They were signed on its behalf by:

Michael Considine
Director
ONE-USE HARM REDUCTION PRODUCTS LTD.

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 January 2026
ONE-USE HARM REDUCTION PRODUCTS LTD.

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 January 2026
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial period, unless otherwise stated.

General information and basis of accounting

One-use Harm Reduction Products Ltd. (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

In 2025 the directors made the decision that the Company would cease trading and that the residual trading activities be transferred to certain fellow group companies. The transfer was finalised in October 2025. As a result the financial statements have been prepared on a basis other than the going concern basis of preparation. The directors have included in the financial statements any provision for future costs of terminating the business, which were committed to at the balance sheet date and where appropriate the Company's assets have been written down to their net realisable value.

Reporting period length

The previous accounting period was from 1 February 2024 to 31 January 2025. This means that they covered a period longer than a year and are not entirely comparable to the current period.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Finance costs

Finance costs are charged to the Statement of Income and Retained Earnings over the term of the debt using the effective interest method so the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Statement of Financial Position date.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Statement of Financial Position date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Ordinary share capital

The ordinary share capital of the Company is presented as equity.

2. Employees

2026 2025
Number Number
Monthly average number of persons employed by the Company during the year, including the director 0 0

3. Debtors

2026 2025
£ £
Trade debtors 0 529
Amounts owed by associates 72,735 56,756
Amounts owed by related parties 7,097 7,097
Amounts owed by director 1,000 1,000
80,832 65,382

4. Creditors: amounts falling due within one year

2026 2025
£ £
Accruals 4,250 4,250
Taxation and social security 67,708 56,046
71,958 60,296

5. Called-up share capital

2026 2025
£ £
Allotted, called-up and fully-paid
1,000 Ordinary shares of £ 1.00 each 1,000 1,000

6. Related party transactions

Transactions with the entity's director

2026 2025
£ £
Amounts due from the Director 1,000 1,000

Other related party transactions

2026 2025
£ £
Amounts owed from a company under common control 72,735 56,756
Amount owed to related party 7,097 7,097